ATE198482T1 - Verfahren zum herstellen von höchstreinem albumin - Google Patents

Verfahren zum herstellen von höchstreinem albumin

Info

Publication number
ATE198482T1
ATE198482T1 AT96904190T AT96904190T ATE198482T1 AT E198482 T1 ATE198482 T1 AT E198482T1 AT 96904190 T AT96904190 T AT 96904190T AT 96904190 T AT96904190 T AT 96904190T AT E198482 T1 ATE198482 T1 AT E198482T1
Authority
AT
Austria
Prior art keywords
albumin
affinity
chromatography
positive mode
highly pure
Prior art date
Application number
AT96904190T
Other languages
German (de)
English (en)
Inventor
Andrew Robert Goodey
Darrell Sleep
Urk Hendrik Van
Stephen Berezenko
John Rodney Woodrow
Richard Alan Johnson
Patricia Carol Wood
Stephen James Burton
Alan Victor Quirk
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Application granted granted Critical
Publication of ATE198482T1 publication Critical patent/ATE198482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT96904190T 1995-05-25 1996-02-29 Verfahren zum herstellen von höchstreinem albumin ATE198482T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/378,859 US5728553A (en) 1992-09-23 1995-05-25 High purity albumin and method of producing
PCT/GB1996/000449 WO1996037515A1 (en) 1995-05-25 1996-02-29 Process of high purity albumin production

Publications (1)

Publication Number Publication Date
ATE198482T1 true ATE198482T1 (de) 2001-01-15

Family

ID=23494845

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96904190T ATE198482T1 (de) 1995-05-25 1996-02-29 Verfahren zum herstellen von höchstreinem albumin
AT00201960T ATE265469T1 (de) 1995-05-25 1996-02-29 Hochreines albumin, durch ein mehrstufiges verfahren hergestellt

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00201960T ATE265469T1 (de) 1995-05-25 1996-02-29 Hochreines albumin, durch ein mehrstufiges verfahren hergestellt

Country Status (15)

Country Link
US (6) US5728553A (enExample)
EP (2) EP1031578B1 (enExample)
JP (4) JP4040088B2 (enExample)
KR (2) KR100566606B1 (enExample)
CN (4) CN100584857C (enExample)
AT (2) ATE198482T1 (enExample)
AU (1) AU698409B2 (enExample)
CA (1) CA2220923C (enExample)
DE (2) DE69611445T2 (enExample)
DK (2) DK1031578T3 (enExample)
ES (2) ES2156991T3 (enExample)
GR (1) GR3035651T3 (enExample)
MX (1) MX9709108A (enExample)
PT (2) PT1031578E (enExample)
WO (1) WO1996037515A1 (enExample)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
DE19538625C2 (de) * 1995-10-17 1999-08-12 Sartorius Gmbh Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
ATE241695T1 (de) * 1996-03-13 2003-06-15 Delta Biotechnology Ltd Gärungs-steuerungssysteme
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
AU2007200859A1 (en) * 1999-01-30 2007-03-22 Novozymes Delta Limited Process
FR2792650B1 (fr) * 1999-04-20 2003-02-28 Oreal Equivalent de peau agee, son procede de preparation et son utilisation
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US8632785B2 (en) 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
CA2494241C (en) * 2000-02-08 2011-06-14 Allergan, Inc. Botulinum toxin pharmaceutical compositions
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2405550A1 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
DK1311269T3 (da) 2000-08-04 2012-03-26 Dmi Biosciences Inc Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
JP4798833B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
CN1275981C (zh) * 2000-10-24 2006-09-20 财团法人化学及血清疗法研究所 人血清白蛋白多聚体的单体化方法
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
US7507413B2 (en) * 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
CA2448432A1 (en) * 2001-06-13 2002-12-19 Taurus Hsa Llc Purification of human serum albumin
ITBO20010426A1 (it) * 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
CA2484556A1 (en) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
EP1465869B1 (en) * 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulators of lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
US20080167238A1 (en) * 2001-12-21 2008-07-10 Human Genome Sciences, Inc. Albumin Fusion Proteins
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
EP1571970B1 (en) * 2002-10-02 2011-08-17 DMI Biosciences, Inc. Diagnosis and monitoring of diseases
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7339347B2 (en) * 2003-08-11 2008-03-04 Reserve Power Cell, Llc Apparatus and method for reliably supplying electrical energy to an electrical system
US8013611B2 (en) * 2006-07-14 2011-09-06 Reserve Power Cell, Llc Vehicle battery product and battery monitoring system
GB0329722D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
GB0329681D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
AU2004313242A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
AU2005205314B2 (en) 2004-01-20 2010-12-09 Km Biologics Co., Ltd. Process for producing human serum albumin by heating in presence of divalent cation
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
WO2005110374A1 (en) * 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US8591885B2 (en) * 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
JP5631533B2 (ja) * 2004-12-23 2014-11-26 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ 遺伝子発現技術
CA2599731A1 (en) * 2005-03-03 2006-09-08 Dmi Biosciences, Inc. Quantification of proteins
US7598700B2 (en) * 2005-03-30 2009-10-06 Reserve Power Cell, Llc Tamper resistant battery and battery warranty and performance tracking system
MY144344A (en) * 2005-04-08 2011-09-15 Ciba Holding Inc Adsorbents comprising anthraquinone dye-ligands for the separation of biological materials
DE102005023155A1 (de) 2005-05-13 2006-11-16 Albutec Gmbh Albuminlösung
US8323666B2 (en) 2005-08-01 2012-12-04 Allergan, Inc. Botulinum toxin compositions
GB0518460D0 (en) * 2005-09-09 2005-10-19 Univ Nottingham Trent Protein assay
DK1989220T3 (da) 2006-02-02 2012-04-02 Trimeris Inc HIV-fusionsinhibitorpeptider med forbedrede biologiske egenskaber
JP2007284425A (ja) * 2006-03-20 2007-11-01 Nokodai Tlo Kk タンパク質の精製方法
EP2046367A4 (en) * 2006-06-07 2009-11-11 Human Genome Sciences Inc ALBUM INFUSION PROTEINS
US9139611B2 (en) 2006-07-13 2015-09-22 Novozymes Biopharma Dk A/S Process for preparing particles of proteinaceous material
ES2371495T3 (es) 2006-07-24 2012-01-03 Biorexis Pharmaceutical Corporation Proteínas de fusión de exendina.
US10829733B2 (en) * 2007-01-04 2020-11-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent human stem cells
JP2010523564A (ja) * 2007-04-03 2010-07-15 トリメリス，インコーポレーテッド 抗ウイルス性ペプチド治療薬の送達のための新規製剤
CN101104635B (zh) * 2007-04-30 2010-11-03 北京济普霖生物技术有限公司 一种从转基因牛乳中纯化重组人α-乳清白蛋白的方法
WO2009019314A1 (en) 2007-08-08 2009-02-12 Novozymes A/S Transferrin variants and conjugates
CN101874038A (zh) * 2007-09-25 2010-10-27 特里梅里斯公司 治疗性抗-hiv肽的合成方法
JP4452324B2 (ja) 2008-03-31 2010-04-21 積水メディカル株式会社 精製血清アルブミン及び免疫学的測定方法
NZ602479A (en) * 2008-05-15 2013-05-31 R Tech Ueno Ltd Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
EP2313430B1 (en) 2008-06-24 2018-05-02 Technische Universität München Muteins of hngal and related proteins with affinity for a given target
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
SG173469A1 (en) 2009-02-20 2011-09-29 Ventria Bioscience Cell culture media containing combinations of proteins
DE102009013914B4 (de) * 2009-03-19 2011-05-05 Bruker Daltonik Gmbh Kalibriersubstanzen für Atmosphärendruck-Ionenquellen
CN102549012B (zh) * 2009-05-07 2015-07-01 诺维信生物制药丹麦公司 纯化白蛋白的方法
CN102612362A (zh) 2009-08-05 2012-07-25 皮里斯股份公司 脂质运载蛋白突变蛋白的控制释放制剂
SG10201408106WA (en) * 2009-08-20 2015-01-29 Baxter Int Purification of vwf for increased removal of non-lipid enveloped viruses
MX2012004793A (es) 2009-10-30 2012-07-20 Novozymes Biopharma Dk As Variantes de albumina.
US9549968B2 (en) 2009-12-07 2017-01-24 Pieris Pharmaceuticals Gmbh Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given target
SG182618A1 (en) * 2010-01-25 2012-08-30 Ventria Bioscience Methods & compositions for improving protein production
JP5969458B2 (ja) 2010-04-09 2016-08-17 アルブミディクス アクティーゼルスカブ アルブミン誘導体及び変異体
SMT201900297T1 (it) 2010-06-08 2019-07-11 Astrazeneca Ab Muteine di lipocalina lacrimale che si legano a il-4 r alfa
CA2808392C (en) 2010-08-16 2020-03-10 Pieris Ag Binding proteins for hepcidin
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
DK2640740T3 (en) 2010-11-15 2017-06-26 Pieris Pharmaceuticals Gmbh MUTEINS OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR GLYPICAN-3 (GPC3)
US9221885B2 (en) 2010-12-02 2015-12-29 Pieris Ag Muteins of human lipocalin 2 with affinity for CTLA-4
PL221899B1 (pl) 2011-05-06 2016-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Czysta albumina oraz sposób jej otrzymywania i detekcji
CN103649111B (zh) 2011-07-05 2018-03-13 阿尔布梅迪克斯医疗公司 白蛋白制剂和用途
BR112014007675A2 (pt) 2011-10-10 2017-04-18 Ampio Pharmaceuticals Inc tratamento de doença articular degenerativa
BR112014007657A2 (pt) 2011-10-10 2017-04-11 Ampio Pharmaceuticals Inc dispositivos médicos implantáveis com tolerância imune aperfeiçoada e métodos para produção e implantação
WO2013063413A1 (en) 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US20140315817A1 (en) 2011-11-18 2014-10-23 Eleven Biotherapeutics, Inc. Variant serum albumin with improved half-life and other properties
SG10201604566QA (en) 2011-12-13 2016-07-28 Pieris Ag Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
DK2825556T3 (en) 2012-03-16 2018-04-16 Albumedix As albumin Variants
US9522940B2 (en) 2012-05-23 2016-12-20 Pieris Pharmaceuticals Gmbh Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3
US20140031527A1 (en) * 2012-07-27 2014-01-30 Csl Limited Method for polishing albumin
KR20150082422A (ko) 2012-11-08 2015-07-15 노보자임스 바이오파마 디케이 에이/에스 알부민 변이체
US20140186447A1 (en) * 2012-12-28 2014-07-03 Abraxis Bioscience, Llc Nanoparticle compositions of albumin and paclitaxel
JP6128677B2 (ja) * 2013-02-05 2017-05-17 公立大学法人大阪市立大学 神経細胞の遊走障害を伴う疾患の判定方法及びその利用
CA2905186A1 (en) 2013-03-14 2014-09-18 Daiichi Sankyo Co., Ltd Novel binding proteins for pcsk9
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CA2891557A1 (en) 2013-03-26 2014-05-22 Pieris Ag Novel specific-binding polypeptides and uses thereof
CN103694343B (zh) * 2013-12-26 2016-05-25 扬州艾迪生物科技有限公司 一种从尿液中制备人血白蛋白的方法
AU2015205530B8 (en) 2014-01-13 2019-09-19 Pieris Pharmaceuticals Gmbh Multi-specific polypeptide useful for localized tumor immunomodulation
DE22197320T1 (de) * 2014-04-30 2024-05-29 Novo-Nordisk A/S Verfahren zur reinigung von proteinen mittels caprylsäure
CN113621050A (zh) 2014-05-22 2021-11-09 皮里斯制药有限公司 新型特异性结合多肽及其用途
EP3183240A4 (en) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
CN104628830A (zh) * 2015-01-23 2015-05-20 深圳康泰生物制品股份有限公司 重组酿酒酵母表达HBsAg的制备工艺及其分离纯化工艺、HBsAg和乙肝疫苗
SG10201906859PA (en) 2015-01-28 2019-08-27 Pieris Pharmaceuticals Gmbh Novel proteins specific for angiogenesis
AR103714A1 (es) 2015-02-18 2017-05-31 Sanofi Sa Proteínas específicas para pioverdina y pioquelina
US10705070B1 (en) 2015-03-05 2020-07-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US10527604B1 (en) 2015-03-05 2020-01-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
US11261221B2 (en) 2015-05-04 2022-03-01 Pieris Pharmaceuticals Gmbh Proteins specific for CD137
CN107636014B (zh) 2015-05-04 2021-12-07 皮里斯制药有限公司 抗癌融合多肽
CN107787327B (zh) 2015-05-18 2022-02-08 皮里斯制药有限公司 对磷脂酰肌醇聚糖-3（gpc3）具有亲和力的人脂质运载蛋白2的突变蛋白
FI3298030T3 (fi) 2015-05-18 2023-02-22 Pieris Pharmaceuticals Gmbh Syöpää ehkäisevä fuusiopolypeptidi
HK1246669A1 (zh) 2015-06-22 2018-09-14 Ampio Pharmaceuticals, Inc. 人血清白蛋白低分子量组分在疾病治疗中的应用
EP3115371A1 (en) 2015-07-07 2017-01-11 Sanofi Fusion molecules
CN108348573A (zh) 2015-07-15 2018-07-31 皮里斯制药有限公司 Lag-3特异性的新型蛋白
EP3337816B1 (en) 2015-08-20 2024-02-14 Albumedix Ltd Albumin variants and conjugates
FR3040882A1 (fr) * 2015-09-10 2017-03-17 Lab Francais Du Fractionnement Composition liquide d'albumine humaine a usage therapeutique
SG11201803732PA (en) 2015-11-30 2018-06-28 Pieris Australia Pty Ltd Novel anti-angiogenic fusion polypeptides
TW201725212A (zh) 2015-12-10 2017-07-16 第一三共股份有限公司 特異性於降鈣素基因相關胜肽的新穎蛋白
CA3005953A1 (en) 2015-12-22 2017-06-29 Albumedix Ltd Improved protein expression strains
JP7146637B2 (ja) 2015-12-22 2022-10-04 アルブミディクス リミティド 改善されたタンパク質発現株
KR102050852B1 (ko) * 2016-03-11 2019-12-03 주식회사 스템온 세포 리프로그래밍 장치
CN118085011A (zh) * 2016-08-17 2024-05-28 勃林格殷格翰国际公司 制备含有生物分子的高度浓缩的液体制剂的方法
EP3429345B1 (en) 2016-10-04 2019-09-11 Albumedix Ltd. Uses of recombinant yeast-derived serum albumin
WO2018087108A1 (en) 2016-11-09 2018-05-17 Pieris Pharmaceuticals Gmbh Proteins specific for cd137
MX2019008434A (es) 2017-01-18 2019-11-11 Pieris Pharmaceuticals Gmbh Muteínas de lipocalina con afinidad de unión por lag-3.
WO2018165766A1 (en) * 2017-03-16 2018-09-20 Therapure Biopharma Inc. Method for purification of albumin
US11130979B2 (en) 2017-06-20 2021-09-28 Albumedix Ltd Protein expression strains
WO2019199476A1 (en) * 2018-04-12 2019-10-17 Amgen Inc. Methods for making stable protein compositions
CN110563833A (zh) * 2018-06-06 2019-12-13 中国计量科学研究院 一种人血白蛋白标准物质原料的制备方法及其产品和应用
AU2019315703A1 (en) 2018-07-31 2020-12-10 Les Laboratoires Servier Novel fusion protein specific for CD137 and PD-L1
CN109734796B (zh) * 2019-02-01 2022-04-15 广州蕊特生物科技有限公司 一种从溶血血清中分离白蛋白的工艺
CN109776673B (zh) * 2019-02-20 2022-03-29 天津理工大学 一种适合中试量产的高纯度牛血清白蛋白纯化工艺
US12486330B2 (en) 2019-02-26 2025-12-02 Pieris Pharmaceuticals Gmbh Fusion proteins specific for CD137 and GPC3
CN110229229A (zh) * 2019-07-10 2019-09-13 甘肃养泰和生物科技有限公司 一种从牛血浆中提取纯化细胞培养级牛血清白蛋白的生产方法及其应用
EP4051241A4 (en) 2019-10-28 2023-12-06 Abraxis BioScience, LLC PHARMACEUTICAL COMPOSITIONS OF ALBUMIN AND RAPAMYCIN
CN116249709A (zh) 2020-06-05 2023-06-09 皮里斯制药有限公司 靶向4-1bb的多聚体免疫调节剂
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
IL300549A (en) * 2020-08-11 2023-04-01 Shenzhen Protgen Ltd Young unblemished human serum albumin that improves human life expectancy
WO2022089639A1 (zh) 2020-10-30 2022-05-05 深圳普罗吉医药科技有限公司 人血清白蛋白在治疗疾病中的应用
CN114885608A (zh) 2020-12-08 2022-08-09 通化安睿特生物制药股份有限公司 纯化重组蛋白的方法
CN112592399B (zh) * 2020-12-15 2024-04-12 甘肃养泰和生物科技有限公司 一种从牛血清中分离牛血清白蛋白的制备方法及装置
CN116744984A (zh) 2020-12-28 2023-09-12 达沃有限公司 包含蛋白质和多官能化改性的基于聚乙二醇的交联剂的反应性干粉状止血材料
EP4320141A1 (en) 2021-04-08 2024-02-14 Pieris Pharmaceuticals GmbH Novel lipocalin muteins specific for connective tissue growth factor (ctgf)
WO2022243341A1 (en) 2021-05-18 2022-11-24 Pieris Pharmaceuticals Gmbh Lipocalin muteins with binding affinity for ox40
CN113735963A (zh) * 2021-09-10 2021-12-03 山东健通生物科技有限公司 一种重组人血清白蛋白纯化过程去除色素的方法
CN114316088B (zh) * 2021-12-22 2022-09-09 中国水产科学研究院黄海水产研究所 亲和树脂、制备方法及其在分离纯化藻蓝蛋白中的应用
TW202428603A (zh) 2022-09-21 2024-07-16 美商思進公司 新穎的cd137及cd228特異性融合蛋白
CN115677848A (zh) * 2022-10-24 2023-02-03 通化安睿特生物制药股份有限公司 一种制备高纯度高稳定性蛋白质的方法
CN116120392B (zh) * 2023-04-18 2023-08-01 上海健士拜生物科技有限公司 聚体蛋白的纯化方法
WO2025175123A1 (en) 2024-02-16 2025-08-21 Seagen Inc. Methods of treating cancer using fusion proteins specific for cd137 and cd228

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019919D0 (en) * 1990-09-12 1990-10-24 Delta Biotechnology Ltd Purification of proteins
US2433905A (en) 1943-11-01 1948-01-06 Jr Walter L Hughes Method for the crystallization of albumin and the preparation of protein products therefrom
AT317418B (de) * 1972-06-16 1974-08-25 Brigitte Panhofer Verfahren zur Herstellung von intravenös beim Menschen anwendbarem Humanalbumin aus menschlichen Placenten
FR2190437B1 (enExample) 1972-07-05 1975-08-08 Merieux Inst
CA1044537A (en) 1973-05-09 1978-12-19 Amf Incorporated Filter medium and process
DE2537123A1 (de) * 1975-08-20 1977-03-03 New Zealand Inventions Dev Verfahren zur herstellung von albumin
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
US4043997A (en) * 1976-05-28 1977-08-23 Cutter Laboratories, Inc. Method for isolating albumin using insoluble supports coupled to a dye
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
IN150740B (enExample) 1978-11-24 1982-12-04 Hoffmann La Roche
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4222934A (en) * 1979-04-12 1980-09-16 American National Red Cross Preparation of albumin using ethanol
GB2053926B (en) 1979-07-20 1983-02-23 Atkinson A Albumin extraction by affinity chromatography
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US4391801A (en) 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung
CA1286622C (en) * 1986-04-28 1991-07-23 Chokyun Rha Method for clarifying and stabilizing cell culture media
JPS62294621A (ja) 1986-06-13 1987-12-22 Green Cross Corp:The アルブミンの回収方法
JPS6383100A (ja) * 1986-09-26 1988-04-13 Green Cross Corp:The ヒト尿中アルブミンの製造方法
US4833233A (en) * 1987-08-20 1989-05-23 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Human serum albumin crystals and method of preparation
IL88326A (en) 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
US4990447A (en) * 1988-06-24 1991-02-05 Gist-Brocades Nv Process for the purification of serum albumin
FR2649991B2 (fr) 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
GB8913586D0 (en) 1989-06-13 1989-08-02 Technicol Limited A method of determining the glycosylated protein level of a sample and an apparatus for use in the method
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
SE500110C2 (sv) 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
JPH0671434B2 (ja) 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
CA2022165C (en) 1989-10-05 1999-11-23 Chong E. Chang Albumin purification
ES2224094T3 (es) * 1990-04-19 2005-03-01 Bayer Corporation Procedimiento para preparar seroalbumina normal (humana) esencialmente monomerica.
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
JP2982296B2 (ja) 1990-11-19 1999-11-22 吉富製薬株式会社 アルブミン含有水溶液の精製法
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
FR2672604B1 (fr) 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5284777A (en) 1991-03-04 1994-02-08 Isolab, Inc. Combined glycated hemoglobin and immunoturbidometric glycated albumin assay from whole blood lysate
US5330901A (en) * 1991-04-26 1994-07-19 Research Corporation Technologies, Inc. Expression of human serum albumin in Pichia pastoris
EP0933083A1 (en) * 1991-07-12 1999-08-04 Dsm N.V. Process for the purification of serum albumin
FR2686620B1 (fr) * 1992-01-27 1995-06-23 Rhone Poulenc Rorer Sa Serum-albumine humaine, preparation et utilisation.
US5281582A (en) * 1992-02-27 1994-01-25 Alliance Pharmaceuticals, Corp. Serum growth factor
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP3360315B2 (ja) * 1992-07-31 2002-12-24 三菱ウェルファーマ株式会社 ヒト血清アルブミンの高度精製方法
DE4226971C2 (de) 1992-08-14 1997-01-16 Widmar Prof Dr Tanner Modifizierte Pilzzellen und Verfahren zur Herstellung rekombinanter Produkte
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
CN1055095C (zh) * 1992-12-11 2000-08-02 上海莱士血制品有限公司 白蛋白的纯化方法
CA2116385A1 (en) * 1993-02-25 1994-08-26 Akinori Sumi Human serum albumin and process for producing the same
SE9301583D0 (sv) 1993-05-07 1993-05-07 Kabi Pharmacia Ab Yeast strain and methods for expressing heterologous proteins in yeast
JP3702474B2 (ja) 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
CA2157219C (en) * 1994-08-31 2010-10-05 Munehiro Noda Process for purifying recombinant human serum albumin
JPH09209303A (ja) 1996-02-05 1997-08-12 Hokkaido Supuritsuton Kogyo Kk 舗装ブロック
AU4837996A (en) 1996-02-29 1997-09-16 Delta Biotechnology Limited High purity albumin production process

Also Published As

Publication number Publication date
EP1031578B1 (en) 2004-04-28
CA2220923A1 (en) 1996-11-28
US6638740B1 (en) 2003-10-28
DK0828759T3 (da) 2001-02-26
CA2220923C (en) 2003-01-07
DE69611445T2 (de) 2001-07-19
US5728553A (en) 1998-03-17
DE69632353D1 (de) 2004-06-03
CN100584857C (zh) 2010-01-27
CN100443499C (zh) 2008-12-17
US20080009042A1 (en) 2008-01-10
KR100543612B1 (ko) 2006-01-20
KR20040077917A (ko) 2004-09-07
AU698409B2 (en) 1998-10-29
US20030187226A1 (en) 2003-10-02
JP4040088B2 (ja) 2008-01-30
JP4372772B2 (ja) 2009-11-25
CN1191545A (zh) 1998-08-26
DE69632353T2 (de) 2005-05-04
ES2156991T3 (es) 2001-08-01
JP4372813B2 (ja) 2009-11-25
US7223561B2 (en) 2007-05-29
HK1009456A1 (en) 1999-06-04
EP1031578A2 (en) 2000-08-30
KR100566606B1 (ko) 2006-12-01
AU4838096A (en) 1996-12-11
WO1996037515A1 (en) 1996-11-28
CN1880334A (zh) 2006-12-20
HK1072436A1 (zh) 2005-08-26
EP1031578A3 (en) 2001-01-17
EP0828759B1 (en) 2001-01-03
US6034221A (en) 2000-03-07
MX9709108A (es) 1998-06-30
PT1031578E (pt) 2004-08-31
ATE265469T1 (de) 2004-05-15
PT828759E (pt) 2001-05-31
GR3035651T3 (en) 2001-06-29
ES2219257T3 (es) 2004-12-01
JP4037174B2 (ja) 2008-01-23
JP2008037867A (ja) 2008-02-21
JP2003048900A (ja) 2003-02-21
DE69611445D1 (de) 2001-02-08
EP0828759A1 (en) 1998-03-18
DK1031578T3 (da) 2004-06-01
JP2006342169A (ja) 2006-12-21
CN100455597C (zh) 2009-01-28
CN1611513A (zh) 2005-05-04
KR19990021994A (ko) 1999-03-25
CN1198844C (zh) 2005-04-27
US7601515B2 (en) 2009-10-13
CN1550504A (zh) 2004-12-01
US20050142636A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
ATE198482T1 (de) Verfahren zum herstellen von höchstreinem albumin
CA2183888A1 (en) Antibody purification
CA2099138A1 (en) Chondroitinase, Process for Preparing the Same, and Pharmaceutical Composition Comprising the Same
CA2265935A1 (en) Heat shock protein complexes
DE69919701D1 (de) Abtrennung von antikörper-monomeren von deren multimeren mittels ionaustausch-chromatographie
ATE221918T1 (de) Zusammensetzungen und methoden zur strukturellen proteinbestimmung
CA2033969A1 (en) Albumin preparation and process for producing same
AU656552B2 (en) Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction
ATE403671T1 (de) Methoden zur aufreinigung von rekombinatem humanem erythropoietin aus zellkulturüberständen
AU7067287A (en) Method and apparatus for separating proteins
AU645094B2 (en) Method of treating bladder cancer cells
AU4764385A (en) Method for silver staining proteins and nucleic acids
Fridriksson et al. Electrospray mass spectra from protein electroeluted from sodium dodecylsulfate polyacrylamide gel electrophoresis gels
CA2199835A1 (en) Method for preparing nucleic acids for analysis and kits useful therefor
CA2223702A1 (en) Therapeutic fragments of von willebrand factor
AU6092498A (en) Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe (viscum album)
ATE272072T1 (de) Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli
CA2274241A1 (en) A process for purifying apolipoprotein a or apolipoprotein e from human plasma
DE59813491D1 (de) Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
GB8817083D0 (en) Improved method of ion exchange & apparatus for carrying out said method
CA2243578A1 (en) High affinity nucleic acid ligands of complement system proteins
JPS57147056A (en) Method for analysis of amino acid
KR960014337A (ko) 신규한 글루탐산 탈수소효소(i) 및 그의 제조방법
KR940003567A (ko) 면역글로불린 a 및 m이 제거된 정맥주사용 감마글로불린제의 제조방법

Legal Events

Date Code Title Description
EEFA Change of the company name
EEIH Change in the person of patent owner